Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma Meeting Abstract


Authors: Slingluff, C. L.; Zarour, H. M.; Postow, M. A.; Friedlander, P. A.; Devoe, C. E.; Smith, K.; Deacon, D.; Macri, M. J.; Ryan, A.; Venhaus, R. R.; Wolchok, J. D.
Abstract Title: Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Language: English
ACCESSION: WOS:000442916004746
DOI: 10.1200/JCO.2018.36.15_suppl.e15175
PROVIDER: wos
Notes: Meeting Abstract: e15175 -- Source: Wos
Altmetric Score
MSK Authors
  1. Jedd D Wolchok
    656 Wolchok
  2. Michael Andrew Postow
    185 Postow